Community-associated methicillin-resistant Staphylococcus aureus: Review of an emerging public health concern

Wisconsin Medical Journal

Volumn 105, Issue 1, 2006, Pages 52-57

  Drews, Timothy D ^a,c   Temte, Jonathan L ^a   Fox, Barry C ^b  

^a UNIVERSITY OF WISCONSIN   (United States)

^b University of Wisconsin Health   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; LINEZOLID; PSEUDOMONIC ACID; TIGECYCLINE; VIRULENCE FACTOR;

ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; CLINICAL FEATURE; COMMUNICABLE DISEASE; COMORBIDITY; CONTROL STRATEGY; DRUG FORMULATION; EPIDEMIOLOGICAL DATA; ERADICATION THERAPY; HEALTH CARE MANAGEMENT; HEALTH CARE SYSTEM; HIGH RISK POPULATION; HUMAN; INFECTION PREVENTION; INFECTION RISK; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PNEUMONIA; PREVENTIVE HEALTH SERVICE; PRIMARY MEDICAL CARE; PUBLIC HEALTH SERVICE; REVIEW; RISK ASSESSMENT; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCUS INFECTION; STATISTICAL SIGNIFICANCE; TREATMENT INDICATION; UNITED STATES;

COMMUNITY-ACQUIRED INFECTIONS; HUMANS; METHICILLIN RESISTANCE; PUBLIC HEALTH; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; UNITED STATES;

EID: 33244464740     PISSN: 10981861     EISSN: 10981861     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. National Nosocomial Infection Surveillance (NNIS) System. NNIS System Report, data summary from January 1992 through June 2004. Am J Infect Control. 2004;32:470-485.
2. Lowy FD. Staphylococcus aureus infections. N Engl J Med. 1998;339:520-532.
3. Centers for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus - Minnesota and North Dakota, 1997-1999. MMWR Morb Mortal Wkly Rep. 1999;48:707-710.
4. Salgado CD, Farr BM, Calfee DP. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis. 2003;36:131-139.
5. Ma XX, Ito T, Tiensasitorn C, et al. Novel type of staphylococcal cassette chromosome mec identified in community-acquired methicillin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother. 2002;46:1147-1152.
6. Fridkin SK, Hageman JC, Morrison M, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med. 2005;352:1436-1444.
7. Naimi TS, LeDell KH, Como-Sabetti K, et al. Comparison of community and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA. 2003;290:2976-2984.
8. Hiramatsu K, Cui L, Kuroda M, Ito T. The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends Microbiol. 2001;9:486-493.
9. Wisplinghoff H, Rosato AE, Enright MC, et al. Related clones containing SCCmec type IV predominate among clinically significant Staphylococcus epidermidis isolates. Antimicrob Agents Chemother. 2003;47:3574-3579.
10. Saiman L, O'Keefe M, Graham PL 3rd, et al. Hospital transmission of community-acquired methicillin-resistant Staphylococcus aureus among postpartum women. Clin Infect Dis. 2003;37:1313-1319.
11. Georgantopoulos P, Storch G, Dunne M, et al. Epidemiological differences between hospital-associated methicillin-resistant Staphylococcus aureus and community-acquired Staphylococcus aureus nasal colonization at the genetic level [abstract]. In: Program and Abstracts of the Infectious Diseases Society of America 43rd Annual Meeting; San Francisco, California; October 6-9, 2004. Abstract 1065.
12. Stemper ME, Shukla SK, Reed KD. Emergence and spread of community-associated methicillin-resistant Staphylococcus aureus in rural Wisconsin, 1989 to 1999. J Clin Microbiol. 2004;42:5673-5680.
13. Carleton HA, Perdreau-Remington F. Rapid increase of the community-associated methicillin-resistant Staphylococcus aureus clone ST8:S (USA300) in a long-term care facility [abstract]. In: Program and Abstracts of the Infectious Diseases Society of America 43rd Annual Meeting; San Francisco, California; October 6-9, 2004. Abstract 1070.
14. Kowalski TJ, Berbari EF, Osmon DR. Epidemiology, treatment, and prevention of community-acquired methicillin-resistant Staphylococcus aureus infections. Mayo Clin Proc. 2005;80:1201-1207.
15. Sanford MD, Widmer AF, Bale MJ, et al. Efficient detection and long-term persistence of the carriage of methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 1994;19:1123.
16. Methicillin-resistant Staphylococcus aureus infections among competitive sports participants - Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000-2003. MMWR Morb Mortal Wkly Rep. 2003;53:793-795.
17. Borlaug G, Davis JP, Fox BC. Community associated methicillin-resistant Staphylococcus aureus: guidelines for clinical management and control of transmission. Wisconsin Division of Public Health; October 2005. Available at: http://dhfs.wisconsin.gov/communicable/pdf_files/CAMRSAGuide_1105.pdf. Accessed January 10, 2006.
18. Lina G, Piemont Y, Godail-Gamot F, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis. 1999;29:1128-1132.
19. Kaplan SL. Implications of methicillin-resistant Staphylococcus aureus as a community-acquired pathogen in pediatric patients. Infect Dis Clin N Am. 2005;19:747-757.
20. Cohen PR, Kurzrock R. Community-acquired methicillin-resistant Staphylococcus aureus skin infection: an emerging clinical problem. J Am Acad Dermatol. 2004;50:277-280.
21. Liassine N, Auckenthaler R, Descombes MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus isolated in Switzerland contains the Panton-Valentine leukocidin or exfoliative toxin genes. J Clin Microbiol. 2004;42:825-828.
22. Gillet Y, Issartel B, Vanhems P, et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotizing pneumonia in young immunocompetent patients. Lancet. 2002;359:753-759.
23. Lee MC, Rios AM, Aten MF, et al. Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin- resistant Staphylococcus aureus. Pediatr Infect Dis J. 2004;23:123-127.
24. Kaplan SL. Treatment of community-associated methicillin-resistant Staphylococcus aureus infections. Pediatr Infect Dis J. 2005;24:457-458.
25. Siberry GK, Tekle T, Carroll K, Dick J. Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro. Clin Infect Dis. 2003;37:1257-1260.
26. Fiebelkorn KR, Crawford SA, McElmeel ML, Jorgensen JH. Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci. J Clin Microbiol. 2003;41:4740-4744.
27. Ellis MW, Hospenthal DR, Dooley DP, et al. Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clin Infect Dis. 2004;39:971.
28. Davis KA, Stewart JJ, Crouch HK, et al. Methicillin-resistant Staphylococcus aureus nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin Infect Dis. 2004;39:776.
29. Kaupland KB, Conly JM. Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: an evidence-based review. Clin Infect Dis. 2003;37:933-938.
30. Thompson FL, Cabezudo I, Wenzel RP. Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Ann Intern Med. 1982;97:309-317.
31. Boyce JM, Pittet D. Health Care Infection Control Practices Advisory Committee. Society for Health Care Epidemiology of America. Association for Professionals in Infection Control. Infectious Diseases Society of America. Hand Hygiene Task Force. Guideline for Hand Hygiene in Health-Care Settings: recommendations of the Health Care Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Infect Contr Hosp Epidemiol. 2002;23(12 suppl):S3-S40.